Newsfilter article unlocker

Enter Newsfilter article ID in the field below.
Example: https://newsfilter.io/articles/39be1bef03e66cdc886c08a2a6319c47

Retrieved article

Private equity firm CVC Capital Partners (CVC.AS) and Belgian investment group Groupe Bruxelles Lambert (GBLB.BR) launched a 10.7 billion euro ($12.43 billion) cash bid for Italy's ​Recordati (RECI.MI) on Friday, aiming to take the company private.

Italy's fragmented pharmaceutical sector has ​seen a flurry of dealmaking in recent months as companies seek ⁠to scale up, with Angelini announcing a $4.1 billion acquisition of U.S.-listed Catalyst Pharmaceuticals (CPRX.O) and Chiesi buying ​U.S.-based KalVista Pharmaceuticals (KALV.O) for 2 billion euros.

CVC, which has since 2018 controlled a vehicle holding ​a 46.8% stake in Recordati, submitted a non-binding expression of interest at the end of March for all of the company’s shares, with the aim of delisting it.

The preliminary offer was subject to a number ​of conditions, including the identification of partners to support the bid, Recordati said at ​that time.

The CVC-GBL consortium is offering 51.29 euros per share in cash ex-dividend, a premium of 12.89% ‌compared ⁠to Recordati's share price on March 25, the day before the Italian company announced CVC's interest.

"CVC and GBL will partner as co-control investors with a clear commitment to support the company's development over the long term," the two partners said in a statement.

The plan ​to take Recordati private ​is aimed at better ⁠exploring options, including potential new deals, across its different business lines to unlock value, a source with direct knowledge of the matter ​told Reuters.

Founded a century ago by Giovanni Recordati as a family ​pharmacy in ⁠a town in central Italy, Recordati now has businesses covering primary care, consumer health and rare diseases. It also supplies other pharmaceutical companies through its chemicals division.

A group of investors ⁠including Abu ​Dhabi Investment Authority (ADIA), Canada Pension Plan Investment Board ​and the company's chairman Andrea Recordati will invest alongside CVC and GBL, the statement added.

($1 = 0.8610 euros)


...